Okay. But Auryxia is a phosphate binder for patients with CKD. The helping with the iron issues was a good secondary outcome and patients would need just the one drug, rather than two, which is great for keeping costs down.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.